Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation.

Published

Journal Article (Review)

BACKGROUND: Lipoatrophic diabetes is an insulin resistance syndrome characterized by the complete or partial lack of adipose tissue and disturbances in lipid and glucose metabolism. Nonalcoholic steatohepatitis (NASH) is a well-described change in liver pathology consisting of steatosis, hepatitis, and fibrosis that can be associated with lipoatrophic diabetes. RESULTS: This article describes the first reported case of lipoatrophic diabetes with NASH leading to liver failure and liver transplantation. Before transplantation, the patient required 600-700 U of insulin/day. After transplantation, a dramatic decline in her insulin requirements was observed, despite corticosteroids. Eighteen months after transplantation, her glycemic control worsened, and she developed recurrent NASH on serial liver biopsies. CONCLUSIONS: NASH associated with lipoatrophic diabetes can recur after liver transplantation, and in this case, was accompanied by increased insulin requirements. These results suggest that the development of NASH itself may contribute to the insulin resistance observed in lipoatrophic diabetes.

Full Text

Duke Authors

Cited Authors

  • Cauble, MS; Gilroy, R; Sorrell, MF; Mailliard, ME; Sudan, DL; Anderson, JC; Wisecarver, JL; Balakrishnan, S; Larsen, JL

Published Date

  • April 15, 2001

Published In

Volume / Issue

  • 71 / 7

Start / End Page

  • 892 - 895

PubMed ID

  • 11349722

Pubmed Central ID

  • 11349722

International Standard Serial Number (ISSN)

  • 0041-1337

Digital Object Identifier (DOI)

  • 10.1097/00007890-200104150-00012

Language

  • eng

Conference Location

  • United States